T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$1.6B |
| 2 |
Verizon
VZ
|
+$1.3B |
| 3 |
US Bancorp
USB
|
+$1.26B |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$1.26B |
| 5 |
Lam Research
LRCX
|
+$1.18B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$6.33B |
| 2 |
Tesla
TSLA
|
+$5.64B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$4.91B |
| 4 |
TMX
Terminix Global Holdings, Inc.
TMX
|
+$3.44B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.4B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.7% |
| 2 | Healthcare | 19.64% |
| 3 | Financials | 12.71% |
| 4 | Consumer Discretionary | 10.95% |
| 5 | Communication Services | 7.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HA
2426
DELISTED
Hawaiian Holdings, Inc.
HA
| $259K | ﹤0.01% |
25,254
+837
| +3% | +$11.2K |
|
2427
Century Aluminum
CENX
$4.59B
| $258K | ﹤0.01% |
31,550
-12,320
| -28% | -$93.1K |
|
|
DHC
2428
Diversified Healthcare Trust
DHC
$2.03B
| $257K | ﹤0.01% |
396,925
+87,230
| +28% | +$86.1K |
|
|
GTHX
2429
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $257K | ﹤0.01% |
47,394
-371
| -0.8% | -$3.11K |
|
2430
Evolus
EOLS
$530M
| $256K | ﹤0.01% |
34,060
+526
| +2% | +$4.07K |
|
|
VTLE
2431
DELISTED
Vital Energy
VTLE
| $256K | ﹤0.01% |
4,977
+271
| +6% | +$16.7K |
|
|
CCF
2432
DELISTED
Chase Corporation
CCF
| $256K | ﹤0.01% |
2,972
-104,658
| -97% | -$9.42M |
|
2433
Beazer Homes USA
BZH
$874M
| $254K | ﹤0.01% |
19,898
+372
| +2% | +$4.52K |
|
2434
Core & Main
CNM
$8.64B
| $253K | ﹤0.01% |
13,065
+3,484
| +36% | +$74.2K |
|
2435
Lightwave Logic
LWLG
$1.12B
| $253K | ﹤0.01% |
58,807
+8,485
| +17% | +$60.2K |
|
2436
Mitek Systems
MITK
$853M
| $252K | ﹤0.01% |
25,966
+5,777
| +29% | +$60.8K |
|
|
SI
2437
DELISTED
Silvergate Capital Corporation
SI
| $252K | ﹤0.01% |
14,483
+352
| +2% | +$14K |
|
2438
NovaGold Resources
NG
$3.4B
| $251K | ﹤0.01% |
41,950
+3,692
| +10% | +$19.7K |
|
2439
Sturm, Ruger & Co
RGR
$601M
| $250K | ﹤0.01% |
4,942
+153
| +3% | +$8.31K |
|
|
KALV
2440
DELISTED
KalVista Pharmaceuticals
KALV
| $249K | ﹤0.01% |
36,879
+9,933
| +37% | +$53.2K |
|
|
SWI
2441
DELISTED
SolarWinds Corporation Common Stock
SWI
| $249K | ﹤0.01% |
26,655
+1,002
| +4% | +$8.75K |
|
|
FSP
2442
Franklin Street Properties
FSP
$46.4M
| $247K | ﹤0.01% |
90,570
+27,292
| +43% | +$75.6K |
|
2443
SiriusPoint
SPNT
$2.7B
| $247K | ﹤0.01% |
41,933
+1,453
| +4% | +$8.54K |
|
|
TBI
2444
Trueblue
TBI
$309M
| $246K | ﹤0.01% |
12,557
-10,511
| -46% | -$213K |
|
2445
Driven Brands
DRVN
$2.12B
| $244K | ﹤0.01% |
8,940
+1,515
| +20% | +$45.3K |
|
2446
Primis Financial Corp
FRST
$413M
| $241K | ﹤0.01% |
20,365
-7,102
| -26% | -$87.3K |
|
2447
UWM Holdings
UWMC
$2.61B
| $241K | ﹤0.01% |
72,760
+17,549
| +32% | +$65.8K |
|
|
FRG
2448
DELISTED
Franchise Group, Inc.
FRG
| $241K | ﹤0.01% |
10,135
+243
| +2% | +$6.34K |
|
2449
Buckle
BKE
$2.31B
| $240K | ﹤0.01% |
+5,283
| New | +$213K |
|
2450
Pure Cycle
PCYO
$273M
| $240K | ﹤0.01% |
22,932
+147
| +0.6% | +$1.38K |
|
Similar funds
T. Rowe Price Associates's Q4 2022 Portfolio in Review
As of Q4 2022, T. Rowe Price Associates held 3,066 positions worth $622B, up 1.8% from $610B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
T. Rowe Price Associates's Q4 2022 filing shows 113 new, 1,569 increased, 1,081 reduced and 107 closed positions. Its largest new stake was GE HealthCare: 6,360,001 shares worth $371M. The largest sale was Amazon, an estimated $6.33B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q4 2022 buy was GE HealthCare: 6,360,001 shares worth $371M.
- T. Rowe Price Associates added most to JPMorgan Chase in Q4 2022, an estimated $1.6B increase.
- T. Rowe Price Associates's biggest Q4 2022 reduction was Amazon, cutting an estimated $6.33B.
- T. Rowe Price Associates fully exited Terminix Global Holdings, Inc. in Q4 2022, selling an estimated $3.44B.
- T. Rowe Price Associates's ten largest holdings make up 27% of its $622B portfolio in Q4 2022.
- T. Rowe Price Associates opened 113 new positions and closed 107 in Q4 2022.
- T. Rowe Price Associates's portfolio value rose 1.8% quarter-over-quarter to $622B.
Based on T. Rowe Price Associates's 13F filing for Q4 2022, filed 14 Feb 2023.